Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Quantification of Interlaboratory Cell-Free Protein Synthesis Variability.

Cole SD, Beabout K, Turner KB, Smith ZK, Funk VL, Harbaugh SV, Liem AT, Roth PA, Geier BA, Emanuel PA, Walper SA, Chávez JL, Lux MW.

ACS Synth Biol. 2019 Sep 20;8(9):2080-2091. doi: 10.1021/acssynbio.9b00178. Epub 2019 Sep 10.

PMID:
31386355
2.

Use of dynamic telepathology utilizing a smartphone in margin control cutaneous surgery.

Emanuel P, Patel R, Liu S, Goldberg M, Romero Sandoval E, Izzard M.

ANZ J Surg. 2019 Jul;89(7-8):982-983. doi: 10.1111/ans.15318. No abstract available.

PMID:
31379076
3.
4.

Muir-Torre syndrome appropriate use criteria: Effect of patient age on appropriate use scores.

Task Force/Committee Members, Vidal CI, Sutton A, Armbrect EA, Lee JB, Litzner BR, Hurley MY; Rating Panel, Alam M, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Robinson JK, Schaffer A.

J Cutan Pathol. 2019 Jul;46(7):484-489. doi: 10.1111/cup.13459. Epub 2019 Apr 26.

PMID:
30895633
5.

Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists.

Emanuel PO, Andea AA, Vidal CI, Missall TA, Novoa RA, Bohlke AK, Hughes SR, Hurley MY, Kim J.

J Cutan Pathol. 2018 Nov;45(11):839-846. doi: 10.1111/cup.13327. Epub 2018 Aug 22. Review.

PMID:
30039879
6.

Low-cost high sensitivity pulsed endomicroscopy to visualize tricolor optical signatures.

Krstajić N, Mills B, Murray I, Marshall A, Norberg D, Craven TH, Emanuel P, Choudhary TR, Williams GOS, Scholefield E, Akram AR, Davie A, Hirani N, Bruce A, Moore A, Bradley M, Dhaliwal K.

J Biomed Opt. 2018 Jul;23(7):1-12. doi: 10.1117/1.JBO.23.7.076005.

7.

PTEN is indispensable for cells to respond to MAPK inhibitors in myeloid leukemia.

Zhang J, Xiang Z, Malaviarachchi PA, Yan Y, Baltz NJ, Emanuel PD, Liu YL.

Cell Signal. 2018 Oct;50:72-79. doi: 10.1016/j.cellsig.2018.06.004. Epub 2018 Jun 28.

PMID:
29964149
8.

Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology.

Task Force/Committee Members, Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Hurley MY; Rating Panel, Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang WL.

J Am Acad Dermatol. 2019 Jan;80(1):189-207.e11. doi: 10.1016/j.jaad.2018.04.033. Epub 2018 Apr 22.

PMID:
29689323
9.

M1 and M2 macrophages differentially regulate hematopoietic stem cell self-renewal and ex vivo expansion.

Luo Y, Shao L, Chang J, Feng W, Liu YL, Cottler-Fox MH, Emanuel PD, Hauer-Jensen M, Bernstein ID, Liu L, Chen X, Zhou J, Murray PJ, Zhou D.

Blood Adv. 2018 Apr 24;2(8):859-870. doi: 10.1182/bloodadvances.2018015685.

10.

Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology.

Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Hurley MY, Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang WL.

J Cutan Pathol. 2018 Aug;45(8):563-580. doi: 10.1111/cup.13142. Epub 2018 Jun 7.

PMID:
29566273
11.

Mycobacterium gordonae-associated skin infection in an immunocompetent patient.

Lee MW, Turnbull N, Emanuel P, Li J.

Australas J Dermatol. 2018 Nov;59(4):e282-e283. doi: 10.1111/ajd.12808. Epub 2018 Mar 8. No abstract available.

PMID:
29516478
12.

Multiple perineuriomatous melanocytic nevi.

Ryder ENC, Turnbull N, Emanuel PO.

J Cutan Pathol. 2018 Jun;45(6):439-442. doi: 10.1111/cup.13134. Epub 2018 Apr 2.

PMID:
29468709
13.

The burden of non-melanoma skin cancers in Auckland, New Zealand.

Pondicherry A, Martin R, Meredith I, Rolfe J, Emanuel P, Elwood M.

Australas J Dermatol. 2018 Aug;59(3):210-213. doi: 10.1111/ajd.12751. Epub 2018 Jan 19.

PMID:
29350397
14.

Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects.

Hutchins LF, Makhoul I, Emanuel PD, Pennisi A, Siegel ER, Jousheghany F, Guo X, Pashov AD, Monzavi-Karbassi B, Kieber-Emmons T.

Oncotarget. 2017 Oct 23;8(58):99161-99178. doi: 10.18632/oncotarget.21959. eCollection 2017 Nov 17.

15.

Erosive Pustular Dermatosis of the Scalp with Urate-Like Crystals.

Emanuel PO, Paul SP.

Case Rep Dermatol Med. 2017;2017:1536434. doi: 10.1155/2017/1536434. Epub 2017 Oct 8.

16.

Time-resolved spectroscopy at 19,000 lines per second using a CMOS SPAD line array enables advanced biophotonics applications.

Kufcsák A, Erdogan A, Walker R, Ehrlich K, Tanner M, Megia-Fernandez A, Scholefield E, Emanuel P, Dhaliwal K, Bradley M, Henderson RK, Krstajić N.

Opt Express. 2017 May 15;25(10):11103-11123. doi: 10.1364/OE.25.011103.

PMID:
28788793
17.

Spindle Cell Lipomas in Women: A Report of 53 Cases.

Ko JS, Daniels B, Emanuel PO, Elson P, Khachaturov V, McKenney JK, Goldblum JR, Billings SD.

Am J Surg Pathol. 2017 Sep;41(9):1267-1274. doi: 10.1097/PAS.0000000000000915.

PMID:
28719462
18.

Spot diagnosis: Progressive cribriform and zosteriform hyperpigmentation.

Cheng H, Sohal S, Lamb S, Carr S, Emanuel P.

Australas J Dermatol. 2018 Feb;59(1):68-69. doi: 10.1111/ajd.12622. Epub 2017 Jul 10. No abstract available.

PMID:
28691379
19.

The Department of Defense Chemical and Biological Defense Program: An Enabler of the Third Offset Strategy.

Roos J, Chue C, DiEuliis D, Emanuel P.

Health Secur. 2017 Mar/Apr;15(2):207-214. doi: 10.1089/hs.2017.0008. Epub 2017 Apr 7.

PMID:
28388218
20.

Managing Expectations in the Transition to Proof of Concept Studies.

Kieber-Emmons T, Makhoul I, Pennisi A, Siegel ER, Emanuel PD, Monzavi-Karbassi B, Steplewski Z, Beck JT, Hutchins LF.

Rev Recent Clin Trials. 2017;12(2):111-123. doi: 10.2174/1574887112666170321121250. Review.

PMID:
28325150
21.

Follicular Porokeratosis, a Porokeratosis Variant.

Tallon B, Emanuel P.

Am J Dermatopathol. 2017 Aug;39(8):e107-e109. doi: 10.1097/DAD.0000000000000850.

PMID:
28266938
22.

Squamous cell carcinoma with enteric adenocarcinomatous differentiation.

Emanuel PO, Desman G, Tallon B.

J Cutan Pathol. 2017 May;44(5):490-493. doi: 10.1111/cup.12910. Epub 2017 Feb 10.

PMID:
28111779
23.

Prior Acute Mental Exertion in Exercise and Sport.

Silva-Júnior FL, Emanuel P, Sousa J, Silva M, Teixeira S, Pires FO, Machado S, Arias-Carrion O.

Clin Pract Epidemiol Ment Health. 2016 Oct 31;12:94-107. eCollection 2016. Review.

24.

Percutaneous hallux valgus treatment: Unilaterally or bilaterally.

Carvalho P, Viana G, Flora M, Emanuel P, Diniz P.

Foot Ankle Surg. 2016 Dec;22(4):248-253. doi: 10.1016/j.fas.2015.11.002. Epub 2015 Dec 9.

PMID:
27810023
25.

A rare case of blastic plasmacytoid dendritic cell neoplasm with deletion 7q.31, in the setting of heavy pre-treatment with alkylating chemotherapy.

Kaur V, Swami A, Shebli A, Shalin S, Veeraputhiran M, Emanuel P, Jethava Y.

J Oncol Pharm Pract. 2017 Oct;23(7):552-556. doi: 10.1177/1078155216665245. Epub 2016 Aug 24.

PMID:
27559020
26.

NRAS and EPHB6 mutation rates differ in metastatic melanomas of patients in the North Island versus South Island of New Zealand.

Jones AM, Ferguson P, Gardner J, Rooker S, Sutton T, Ahn A, Chatterjee A, Bickley VM, Sarwar M, Emanuel P, Kenwright D, Shepherd PR, Eccles MR.

Oncotarget. 2016 Jul 5;7(27):41017-41030. doi: 10.18632/oncotarget.9351.

27.

Multigeneration Cross-Contamination of Mail with Bacillus anthracis Spores.

Edmonds J, Lindquist HD, Sabol J, Martinez K, Shadomy S, Cymet T, Emanuel P.

PLoS One. 2016 Apr 28;11(4):e0152225. doi: 10.1371/journal.pone.0152225. eCollection 2016.

28.

Polymorphous sweat gland carcinoma: a report of two cases.

Walker A, Mesinkovska NA, Emanuel PO, Vidimos A, Billings SD.

J Cutan Pathol. 2016 Jul;43(7):594-601. doi: 10.1111/cup.12695. Epub 2016 Apr 5.

PMID:
26956440
29.

Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancy.

Liu YL, Yan Y, Webster C, Shao L, Lensing SY, Ni H, Feng W, Colorado N, Pathak R, Xiang Z, Hauer-Jensen M, Li S, Zhou D, Emanuel PD.

Blood. 2016 Apr 14;127(15):1912-22. doi: 10.1182/blood-2015-05-646216. Epub 2016 Jan 13.

30.

Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia.

Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen SR, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA, Briones M, Carcamo B, Cooper T, Dahl GV, Emanuel PD, Fluchel MN, Goyal RK, Hayashi RJ, Hitzler J, Hugge C, Liu YL, Messinger YH, Mahoney DH Jr, Monteleone P, Nemecek ER, Roehrs PA, Schore RJ, Stine KC, Takemoto CM, Toretsky JA, Costello JF, Olshen AB, Stewart C, Li Y, Ma J, Gerbing RB, Alonzo TA, Getz G, Gruber TA, Golub TR, Stegmaier K, Loh ML.

Nat Genet. 2016 Jan;48(1):101. doi: 10.1038/ng0116-101a. No abstract available.

PMID:
26711114
31.

The genomic landscape of juvenile myelomonocytic leukemia.

Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen S, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA, Briones M, Carcamo B, Cooper T, Dahl GV, Emanuel PD, Fluchel MN, Goyal RK, Hayashi RJ, Hitzler J, Hugge C, Liu YL, Messinger YH, Mahoney DH Jr, Monteleone P, Nemecek ER, Roehrs PA, Schore RJ, Stine KC, Takemoto CM, Toretsky JA, Costello JF, Olshen AB, Stewart C, Li Y, Ma J, Gerbing RB, Alonzo TA, Getz G, Gruber T, Golub T, Stegmaier K, Loh ML.

Nat Genet. 2015 Nov;47(11):1326-1333. doi: 10.1038/ng.3400. Epub 2015 Oct 12. Erratum in: Nat Genet. 2015 Nov;47(11):1333. Nat Genet. 2016 Jan;48(1):101.

32.

Predicting lymph node metastases in cutaneous squamous cell carcinoma: use of a morphological scoring system.

Agar NJ, Kirton C, Patel RS, Martin RC, Angelo N, Emanuel PO.

N Z Med J. 2015 Mar 27;128(1411):59-67.

PMID:
25820504
33.

MYC amplification in multiple marker chromosomes and EZH2 microdeletion in a man with acute myeloid leukemia.

Xiang Z, Abdallah AO, Govindarajan R, Mehta P, Emanuel PD, Papenhausen P, Schichman SA.

Cancer Genet. 2015 Mar;208(3):96-100. doi: 10.1016/j.cancergen.2015.01.010. Epub 2015 Feb 7.

PMID:
25800664
34.

Persisting extreme acute corneal hydrops with a giant intrastromal cleft secondary to keratoconus.

Gokul A, Krishnan T, Emanuel PO, Saunders M, McGhee CNj.

Clin Exp Optom. 2015 Sep;98(5):483-6. doi: 10.1111/cxo.12260. Epub 2015 Mar 5. No abstract available.

35.

Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.

Stieglitz E, Ward AF, Gerbing RB, Alonzo TA, Arceci RJ, Liu YL, Emanuel PD, Widemann BC, Cheng JW, Jayaprakash N, Balis FM, Castleberry RP, Bunin NJ, Loh ML, Cooper TM.

Pediatr Blood Cancer. 2015 Apr;62(4):629-36. doi: 10.1002/pbc.25342. Epub 2014 Dec 8.

36.

Natural history of chronic myelomonocytic leukemia: gene sequencing identifies multiple clonal molecular abnormalities associated with rapid progression to acute myeloid leukemia.

Xiang Z, Kaur V, Aburiziq IK, Mehta P, Emanuel P, Schichman SA.

Clin Case Rep. 2014 Dec;2(6):265-70. doi: 10.1002/ccr3.110. Epub 2014 Nov 13.

37.

Proteasome-associated autoinflammatory syndromes: advances in pathogeneses, clinical presentations, diagnosis, and management.

McDermott A, Jacks J, Kessler M, Emanuel PD, Gao L.

Int J Dermatol. 2015 Feb;54(2):121-9. doi: 10.1111/ijd.12695. Epub 2014 Dec 18. Review.

PMID:
25521013
38.

Moving a Carbohydrate Mimetic Peptide into the clinic.

Makhoul I, Hutchins L, Emanuel PD, Pennisi A, Siegel E, Jousheghany F, Monzavi-Karbassi B, Kieber-Emmons T.

Hum Vaccin Immunother. 2015;11(1):37-44. doi: 10.4161/hv.34300. Epub 2014 Nov 1.

39.

Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia.

Stieglitz E, Troup CB, Gelston LC, Haliburton J, Chow ED, Yu KB, Akutagawa J, Taylor-Weiner AN, Liu YL, Wang YD, Beckman K, Emanuel PD, Braun BS, Abate A, Gerbing RB, Alonzo TA, Loh ML.

Blood. 2015 Jan 15;125(3):516-24. doi: 10.1182/blood-2014-09-601690. Epub 2014 Nov 13.

40.

Periocular intralymphatic histiocytosis or localized Melkersson-Rosenthal syndrome?

Emanuel PO, Lewis I, Gaskin B, Rosser P, Angelo N.

J Cutan Pathol. 2015 Apr;42(4):289-94. doi: 10.1111/cup.12419. Epub 2015 Feb 3.

PMID:
25370527
41.

Hallway gossip between Ras and PI3K pathways.

Emanuel PD.

Blood. 2014 May 1;123(18):2751-3. doi: 10.1182/blood-2014-03-559039.

PMID:
24786454
42.

Mutations in GATA2 are rare in juvenile myelomonocytic leukemia.

Stieglitz E, Liu YL, Emanuel PD, Castleberry RP, Cooper TM, Shannon KM, Loh ML.

Blood. 2014 Feb 27;123(9):1426-7. doi: 10.1182/blood-2013-11-531079. No abstract available.

43.

Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase chronic myeloid leukaemia.

Deininger MW, Kopecky KJ, Radich JP, Kamel-Reid S, Stock W, Paietta E, Emanuel PD, Tallman M, Wadleigh M, Larson RA, Lipton JH, Slovak ML, Appelbaum FR, Druker BJ.

Br J Haematol. 2014 Jan;164(2):223-32. doi: 10.1111/bjh.12618. Epub 2013 Nov 4.

44.

Differentiation between malignant melanoma and Spitz tumour has improved over the past decade due to modern pathological techniques.

Ng D, McKerrow KJ, Oei P, Tallon B, Emanuel PO.

N Z Med J. 2013 Aug 30;126(1381):87-91.

PMID:
24150269
45.

Combined cellular blue nevus and trichoepithelioma.

Martin R, Emanuel P.

J Clin Aesthet Dermatol. 2013 Aug;6(8):35-8.

46.

A case of proteasome-associated auto-inflammatory syndrome with compound heterozygous mutations.

McDermott A, Jesus AA, Liu Y, Kim P, Jacks J, Montealegre Sanchez GA, Chen Y, Kannan A, Schnebelen A, Emanuel PD, Shalin S, Hiatt K, Goldbach-Mansky R, Gao L.

J Am Acad Dermatol. 2013 Jul;69(1):e29-32. doi: 10.1016/j.jaad.2013.01.015. No abstract available.

47.

Deficiency of CREB and over expression of miR-183 in juvenile myelomonocytic leukemia.

Liu YL, Lensing SY, Yan Y, Cooper TM, Loh ML, Emanuel PD.

Leukemia. 2013 Jul;27(7):1585-8. doi: 10.1038/leu.2013.49. Epub 2013 Feb 18. No abstract available.

48.

Nail plate clues to a remote diagnosis.

Tallon B, Strydom F, Emanuel PO.

J Cutan Pathol. 2013 Jan;40(1):2-3. doi: 10.1111/cup.12071. No abstract available.

PMID:
23278722
49.

Detection and tracking of a novel genetically tagged biological simulant in the environment.

Emanuel PA, Buckley PE, Sutton TA, Edmonds JM, Bailey AM, Rivers BA, Kim MH, Ginley WJ, Keiser CC, Doherty RW, Kragl FJ, Narayanan FE, Katoski SE, Paikoff S, Leppert SP, Strawbridge JB, VanReenen DR, Biberos SS, Moore D, Phillips DW, Mingioni LR, Melles O, Ondercin DG, Hirsh B, Bieschke KM, Harris CL, Omberg KM, Rastogi VK, Van Cuyk S, Gibbons HS.

Appl Environ Microbiol. 2012 Dec;78(23):8281-8. doi: 10.1128/AEM.02006-12. Epub 2012 Sep 21.

50.

Genetic barcodes for improved environmental tracking of an anthrax simulant.

Buckley P, Rivers B, Katoski S, Kim MH, Kragl FJ, Broomall S, Krepps M, Skowronski EW, Rosenzweig CN, Paikoff S, Emanuel P, Gibbons HS.

Appl Environ Microbiol. 2012 Dec;78(23):8272-80. doi: 10.1128/AEM.01827-12. Epub 2012 Sep 21.

Supplemental Content

Loading ...
Support Center